These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19916120)

  • 41. The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers.
    Smink BE; Lusthof KJ; de Gier JJ; Uges DR; Egberts AC
    J Forensic Leg Med; 2008 Nov; 15(8):483-8. PubMed ID: 18926498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prescription drugs, drugged driving and per se laws.
    Voas RB; DuPont RL; Shea CL; Talpins SK
    Inj Prev; 2013 Jun; 19(3):218-21. PubMed ID: 23024170
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fixed limits for central stimulants in traffic].
    Vindenes V; Slørdal L; Mørland J
    Tidsskr Nor Laegeforen; 2012 Feb; 132(3):275-6. PubMed ID: 22314734
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
    Buchan BJ; Walsh JM; Leaverton PE
    J Forensic Sci; 1998 Mar; 43(2):395-9. PubMed ID: 9544550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment.
    Jones AW
    Addiction; 2007 Jul; 102(7):1085-91. PubMed ID: 17498183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substance use as a predictor of driving under the influence (DUI) rearrests. a 15-year retrospective study.
    Impinen A; Rahkonen O; Karjalainen K; Lintonen T; Lillsunde P; Ostamo A
    Traffic Inj Prev; 2009 Jun; 10(3):220-6. PubMed ID: 19452362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applying Stafford and Warr's reconceptualization of deterrence theory to drug driving: can it predict those likely to offend?
    Watling CN; Palk GR; Freeman JE; Davey JD
    Accid Anal Prev; 2010 Mar; 42(2):452-8. PubMed ID: 20159066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
    Biermann T; Schwarze B; Zedler B; Betz P
    Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in drug use of Scottish drivers arrested under Section 4 of the Road Traffic Act--a 10 year review.
    Officer J
    Sci Justice; 2009 Dec; 49(4):237-41. PubMed ID: 20120600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
    Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
    Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of licit and illicit drugs in traffic (Hungary 2000-2007).
    Tóth AR; Varga T; Molnár A; Hideg Z; Somogyi G
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S419-22. PubMed ID: 19278887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concentration of drugs in blood of suspected impaired drivers.
    Augsburger M; Donzé N; Ménétrey A; Brossard C; Sporkert F; Giroud C; Mangin P
    Forensic Sci Int; 2005 Oct; 153(1):11-5. PubMed ID: 15923096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hair drug testing in the new Brazilian regulation to obtain professional driver's licence: no parallel to any other law enforcement in the world.
    Leyton V; Andreuccetti G; de Almeida RM; Muñoz DR; Walls HC; Greve JM; da Costa Montal JH; Adura FE; Yonamine M
    Addiction; 2015 Jul; 110(7):1207-8. PubMed ID: 25967396
    [No Abstract]   [Full Text] [Related]  

  • 54. Suspected impaired driving case involving α-pyrrolidinovalerophenone, methylone and ethylone.
    Knoy JL; Peterson BL; Couper FJ
    J Anal Toxicol; 2014 Oct; 38(8):615-7. PubMed ID: 25217556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood synthetic cannabinoid concentrations in cases of suspected impaired driving.
    Yeakel JK; Logan BK
    J Anal Toxicol; 2013 Oct; 37(8):547-51. PubMed ID: 23965292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventing cannabis users from driving under the influence of cannabis.
    Jones C; Donnelly N; Swift W; Weatherburn D
    Accid Anal Prev; 2006 Sep; 38(5):854-61. PubMed ID: 16574046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drugs in oral fluid in randomly selected drivers.
    Drummer OH; Gerostamoulos D; Chu M; Swann P; Boorman M; Cairns I
    Forensic Sci Int; 2007 Aug; 170(2-3):105-10. PubMed ID: 17658711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Opinionating difficulties in cases concerning the use of psychoactive agents by traffic participants].
    Olszowy Z; Albert M; Celiński R; Kulikowska J; Rojek S
    Arch Med Sadowej Kryminol; 2007; 57(2):210-4. PubMed ID: 17691178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of psychoactive drug use among drivers in Thailand: a roadside survey.
    Ingsathit A; Woratanarat P; Anukarahanonta T; Rattanasiri S; Chatchaipun P; Wattayakorn K; Lim S; Suriyawongpaisal P
    Accid Anal Prev; 2009 May; 41(3):474-8. PubMed ID: 19393795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A drug evaluation and classification program in the USA--also a model for Germany].
    Hein PM; Schulz E
    Blutalkohol; 1992 Jul; 29(4):226-41. PubMed ID: 1503702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.